Merck Serono DreaMS of securing MS franchise with Ono deal
This article was originally published in Scrip
Executive Summary
Merck Serono has signed two collaboration agreements with Japan's Ono Pharmaceutical with a view to strengthening two of its franchises, those covering multiple sclerosis (MS) and cancer.